By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Provectus Biopharmaceuticals Inc. 

7327 Oak Ridge Highway
Suite B
Knoxville  Tennessee  37931  U.S.A.
Phone: 866-594-5999 Fax:


Company News
Provectus Announces Publication Of Two Abstracts On Research Into IL PV-10 For Melanoma In Special Issue Of ANZ Journal Of Surgery 4/28/2016 9:51:56 AM
Provectus To Participate In Panel At Third International Conference On The Progress Of Regenerative Medicine And Its Cultural Impact 4/27/2016 11:12:08 AM
Provectus Reports Data On PV-10 In Combination Therapy And T Cell Mediated Immunity Presented At AACR Annual Meeting 2016 4/22/2016 9:14:11 AM
Provectus Reports Trials In Progress Abstract Accepted For Poster Presentation At ASCO Annual Meeting 4/21/2016 10:15:30 AM
Provectus Reports Fourth Quarter And Year End 2015 Financial Results 3/31/2016 11:29:08 AM
Provectus To Host Its Quarterly Year-End 2015 Financial Business Update Conference Call Wednesday, March 30, 2016 At 4 Pm (EDT) 3/24/2016 8:12:19 AM
Provectus Announces Abstract Publicly Available For Poster Presentation On PV-10 In Combination Therapy And T Cell Mediated Immunity 3/18/2016 10:24:31 AM
Provectus Amends Protocol For Phase 3 Study Of PV-10 In Treatment Of Locally Advanced Cutaneous Melanoma 3/16/2016 9:29:04 AM
Investigation Finds Ex-Provectus CEO Did Not Produce Travel Documentation, May Have Altered Receipts 3/16/2016 6:11:10 AM
Provectus To Host Fourth Quarter, Year-End 2015 Conference Call Wednesday, March 16, 2016, At 4 PM EDT 3/11/2016 10:27:33 AM